Is IMRX or INBX more undervalued in 2026?

CirclFi compares Immuneering Corporation (IMRX) and Inhibrx Biosciences, Inc. (INBX) using 13 institutional-grade valuation models. IMRX has a Quality of Company score of 4.5/10 while INBX scores 5.3/10.

Which is a better buy — IMRX or INBX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IMRX and INBX valuations compare?

IMRX at $5.06 and INBX at $103.98 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IMRX vs INBX Valuation Comparison 2026 — Intrinsic Value Analysis

IMRX

Biotechnology

Immuneering Corporation

Quality

4.5

out of 10

Value Trap

LOW

Price

$5.06

Last close

Models

7/13

Active

INBX

Biotechnology

Inhibrx Biosciences, Inc.

Quality

5.3

out of 10

Value Trap

SAFE

Price

$103.98

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	IMRX Fair Value	IMRX Upside	INBX Fair Value	INBX Upside
Bayesian DCF	Intrinsic	$1.74	-65.7%	$28.69	-72.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.66	-67.2%	—	—
Dynamic NAV	Asset-Based	$2.65	-47.7%	$2.89	-97.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMRX vs INBX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMRX vs INBX — Which Stock Is More Undervalued?

INBX scores higher with a 5.3/10 quality rating vs IMRX's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Immuneering Corporation (IMRX) and Inhibrx Biosciences, Inc. (INBX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMRX currently trades at $5.06 with a QOC of 4.5/10, while INBX trades at $103.98 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).